Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma

Martin Glas Department of Neurology, University of Regensburg, Regensburg, Germany; Clinical Neurooncology Unit, Department of Neurology, University of Bonn, Bonn, GermanyCorrespondence[email protected]

Burkhard Hennemann Department of Hematology and Oncology, Internal Medicine, University of Regensburg, Regensburg, Germany

Birgit Hirschmann Department of Neurology, University of Regensburg, Regensburg, Germany

Jörg Marienhagen Department of Nuclear Medicine, University of Regensburg, Regensburg, Germany

Ingo Schmidt-Wolf Department of Internal Medicine I, University of Bonn, Germany

Ulrich Herrlinger Clinical Neurooncology Unit, Department of Neurology, University of Bonn, Bonn, Germany

Ulrich Bogdahn Department of Neurology, University of Regensburg, Regensburg, Germany

Peter Hau Department of Neurology, University of Regensburg, Regensburg, Germany

show all

References

Herrlinger U, Steinbrecher A, Rieger J, Hau P, Kortmann RD, Meyermann R, et al. Adult medulloblastoma: Prognostic factors and response to therapy at diagnosis and at relapse. J Neurol 2005; 252: 291–9
PubMed Web of Science ®Google Scholar
Fruhwald MC, O'Dorisio MS, Pietsch T, Reubi JC. High expression of somatostatin receptor 2 (sst2) in medulloblastoma: Implications for diagnosis and therapy. Pediatr Res 1999; 45: 697–708
PubMedGoogle Scholar
Florio T, Morino M, Villa V, Arena S, Corsaro A, Thellung S, et al. Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. Endocrinology 2003; 144: 1574–84
PubMed Web of Science ®Google Scholar
Kwaan HC, Gordon LI. Thrombotic microangiopathy in the cancer patient. Acta Haematol 2001; 106: 52–6
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date